Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-09-29 7:49 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | BB BIOTECH AG | 4,602,562 5.2% | 4,602,562 (New Position) | View |
2022-06-27 4:33 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | EcoR1 Capital LLC | 4,278,069 5.8% | 4,278,069 (New Position) | View |
2022-05-10 10:13 am Sale | 13G | REVOLUTION MEDICINES INC RVMD | FMR LLC | 186,261 0.25% | -5,915,463 (-96.95%) | View |
2022-02-14 5:02 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | Third Rock Ventures III L.P. | 5,653,290 7.7% | -3,295,779 (-36.83%) | View |
2022-02-14 3:10 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management LP | 2,431,852 3.3% | -1,243,148 (-33.83%) | View |
2022-02-11 8:57 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.5% | -1,946,500 (-51.81%) | View |
2022-02-11 4:23 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | COLUMN GROUP III LP | 3,347,199 4.5% | -233,007 (-6.51%) | View |
2022-02-10 08:32 am Purchase | 13G | REVOLUTION MEDICINES INC RVMD | VANGUARD GROUP INC | 6,299,609 8.55% | 2,261,789 (+56.02%) | View |
2022-02-04 09:22 am Purchase | 13G | REVOLUTION MEDICINES INC RVMD | WELLINGTON MANAGEMENT GROUP LLP | 4,510,895 6.12% | 4,510,895 (New Position) | View |
2022-02-03 4:41 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | BlackRock Inc. BLK | 5,475,219 7.4% | 1,963,132 (+55.90%) | View |
2022-01-10 1:26 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | FMR LLC | 6,101,724 8.28% | -3,237,761 (-34.67%) | View |
2021-05-19 4:09 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management LP | 3,675,000 5% | 1,179,934 (+47.29%) | View |
2021-05-17 4:49 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | BIOTECHNOLOGY VALUE FUND L P | 3,757,049 5.1% | 3,757,049 (New Position) | View |
2021-02-16 4:50 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Boxer Capital LLC | 3,309,264 4.6% | 49,500 (+1.52%) | View |
2021-02-16 4:09 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Third Rock Ventures III L.P. | 8,949,069 13.5% | 8,949,069 (New Position) | View |
2021-02-16 3:00 pm Sale | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management LP | 2,495,066 3.8% | -750,111 (-23.11%) | View |
2021-02-12 6:25 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | COLUMN GROUP III LP | 3,580,206 4.9% | 3,580,206 (New Position) | View |
2021-02-11 10:46 am Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Sanofi SNY | 3,363,050 4.6% | 3,363,050 (New Position) | View |
2021-02-10 11:47 am Purchase | 13G | REVOLUTION MEDICINES INC RVMD | VANGUARD GROUP INC | 4,037,820 6.08% | 4,037,820 (New Position) | View |
2021-02-08 10:31 am Purchase | 13G | REVOLUTION MEDICINES INC RVMD | FMR LLC | 9,339,485 14.069% | 2,675,422 (+40.15%) | View |